| 发明名称 |
USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C] QUINAZOLINES FOR THE TREATMENT OF CANCER |
| 摘要 |
<p>The present invention relates to 2,3-dihydroimidazo(1,2-c)quinazoline derivatives as inhibitors of P13K kinase for the treatment or prophylaxis of a disease, particularly for the treatment of cancers and their metastases.</p> |
| 申请公布号 |
WO2015082376(A3) |
申请公布日期 |
2015.07.30 |
| 申请号 |
WO2014EP76051 |
申请日期 |
2014.12.01 |
| 申请人 |
BAYER PHARMA AKTIENGESELLSCHAFT |
发明人 |
NINGSHU, LIU;SCHOLZ, ARNE;HÄGEBARTH, ANDREA |
| 分类号 |
A61K45/06;A61K31/517;A61K31/519;A61K31/5377;A61P35/00 |
主分类号 |
A61K45/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
